Annual report pursuant to Section 13 and 15(d)

Note K - Equity-based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details)

v3.20.4
Note K - Equity-based Compensation - Summary of Stock-settled Stock Appreciation Right Activity (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 02, 2021
Dec. 28, 2019
Outstanding, shares (in shares) 1,129  
Outstanding, weighted-average exercise price (in dollars per share) $ 70.00  
Outstanding, weighted-average remaining contractual term (Year) 2 years 1 year 1 month 6 days
Outstanding, aggregate intrinsic value [1] $ 5,434 $ 13,091
Granted, shares (in shares) 111  
Granted, weighted-average exercise price (in dollars per share) $ 63.02  
Exercised, shares (in shares) (681)  
Exercised, weighted-average exercise price (in dollars per share) $ 69.24  
Forfeited, shares (in shares) 0  
Forfeited, weighted-average exercise price (in dollars per share) $ 0  
Expired, shares (in shares) (115)  
Expired, weighted-average exercise price (in dollars per share) $ 70.75  
Outstanding, shares (in shares) 444 1,129
Outstanding, weighted-average exercise price (in dollars per share) $ 69.25 $ 70.00
Exercisable, shares (in shares) 170  
Exercisable, weighted-average exercise price (in dollars per share) $ 67.16  
Exercisable, weighted-average remaining contractual term (Year) 1 year 3 months 18 days  
Exercisable, aggregate intrinsic value $ 2,177  
[1] Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company’s common stock on the last trading day of the period) and the exercise price of awards that were in-the-money. The closing price of the Company’s common stock at January 2, 2021, and December 28, 2019, was $80.00 and $114.96, respectively.